Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Your right, this things warrants keeping a close eye on. Things could happen fast.
Anything is possible. The company will either re-emerge as a new entity with a new direction, do a reverse merger, or fold.
Without clarification from them in the form of a PR or some kind of filing, this could trade sideways for weeks, or even go down further.
Or volume - and the PPS - could suddenly increase based on info we don't have access to.
Hard to say at this point.
JMO
It's the end of the old business and on to the next here. Watching for acquisition news or possibly a reverse merger.
MYRX GOING TO DA MOON~!!!!!!!
WEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE
I'm hoping a stock alert site is loading, then out comes all the bs emails and up, up, up, we go.
On the other hand it seems odd to me for the co. to distribute $3/share divvys when they are considering closing the doors?? If the co. owned a huge portion of the shares and gave a large smount to themselves?? Knowing for whatever reason the ticker would plummet and they could rebuy more shares ar roughly 1/20th of the price?? Somethings up anyways, I think? jmo
The last 10Q seems to indicate a suspension of development activities, and a transfer to 'third parties'...
You could be right sandtrap. A tiny share structure could spring this one right back up. Will be watching this one close over the next few days for some developments. GL!
Good question. Not completely sure where this is going, but believe it's undervalued. All of the facts not yet available IMO.
5.4 mil vol today. Accumulation is up and the RSI is in the dirt.
Kind of like a spring that's been stretched out and now about to recoil...UP.
Took a small position today.
GLTA
Yeah .18 former (very recently) NASDAQ company looking to add value. We'll see. gl
Looks pretty interesting so far marketraider.
pretty much looks that way
Per their last 10q they had 44.3m cash and 36.9m in Marketable investment securities. Did they pay out the cash and still have the 36.9m in Marketable investment securities?
No asset sell, just paid a $2.86 distribution and moved to the OTCBB
Email from the company:
Yes it was paid February 15, 2013.
Kind regards,
Andrea Kendell
Myrexis, Inc.
Chief Financial Officer
305 Chipeta Way
Salt Lake City, Utah 84108
Tel: 801.214.7879
Fax: 801.214.7992
Cell: 801.673.3911
From: xxxxxxxxxxxxxxxx
Sent: Tuesday, February 19, 2013 12:50 PM
To: Investor Relations
Subject: Cash Distribution
Has the $2.86 special cash distribution been paid yet? If not can you tell me when the distribution will be paid?
Thank you,
xxxxxxxxxxxxxxxxxxx
So, it looks like they are still in business, but just looking for new opportunities now. Do you know if they got rid of all their assets?
You need to read this:
"After a lengthy review and evaluation of potential alternatives to the Company's liquidation and dissolution, including consideration of advice provided by the Company's financial advisor, Stifel Nicolaus Weisel, the Board of Directors reached the conclusion that it is in the best interests of the shareholders to terminate further consideration of dissolution, appoint Jonathan M. Couchman as Director, President and Chief Executive Officer of the Company, and distribute $2.86 per share to the shareholders. Mr. Couchman has an established track record in creating value for shareholders, and he will endeavor to identify and cause the company to acquire one or more revenue or income producing assets," stated Gerald P. Belle, Chairman of the Board of Directors. "We believe that these arrangements will maximize value to our shareholders by providing an immediate substantial cash distribution to shareholders, while preserving and enhancing the opportunity to derive additional value in the future."
http://investors.myrexis.com/releasedetail.cfm?ReleaseID=735228
Interesting... Last q shows 83m in assets, of which 44m was cash..... But, I guess the news says it all:
Myrexis, Inc. Announces Board Approval of Plan of Complete Liquidation and Dissolution
Myrexis, (MM) (NASDAQ:MYRX)
Historical Stock Chart
6 Months : From Aug 2012 to Feb 2013
Myrexis, Inc. (Nasdaq:MYRX) today announced that its Board of Directors has determined, after extensive and careful consideration of potential strategic alternatives, that it is in the best interests of the Company and its shareholders to dissolve the Company and liquidate its assets. In connection with the dissolution and liquidation, which is subject to shareholder approval, the Company intends to distribute to its shareholders all available cash, except such cash as is required for paying or making reasonable provision for known and potential liabilities and other obligations of the Company.
Plan of Complete Liquidation and Dissolution
The Board of Directors has unanimously approved the dissolution and liquidation of the Company, subject to shareholder approval. The Company intends to call a special meeting of the shareholders to seek approval of a Plan of Complete Liquidation and Dissolution (the "Plan of Dissolution") and will file proxy materials with the Securities and Exchange Commission as soon as practicable.
"After evaluating the Company's strategic options, the Board of Directors reached the conclusion that it is in the best interest of the shareholders to dissolve and liquidate the Company," stated Gerald P. Belle, Chairman of Myrexis' Board of Directors. "The Board of Directors and management, together with its external advisors, devoted substantial time and effort in identifying and pursuing opportunities to enhance shareholder value; however, that process did not yield a potential transaction which the Board viewed as reasonably likely to provide greater realizable value to its shareholders than the complete dissolution and liquidation of the Company in accordance with the Plan of Dissolution."
The Plan of Dissolution contemplates an orderly wind down of the Company's business and operations. If the Company's shareholders approve the Plan of Dissolution, the Company intends to file a certificate of dissolution, delist its shares from The NASDAQ Global Market, satisfy or resolve its remaining liabilities and obligations, including but not limited to contingent liabilities and claims and costs associated with the dissolution and liquidation, make reasonable provisions for unknown claims and liabilities, attempt to convert all of its remaining assets into cash or cash equivalents, and make distributions to its shareholders of cash available for distribution based upon their proportionate ownership at the time of the dissolution, subject to applicable legal requirements.
The Company currently estimates that it will establish a reserve of between $7 million and $12 million, which will be used to pay all expenses (including operating expenses up until the dissolution) and other known, non-contingent liabilities, and includes reasonable provision for expenses of liquidation and contingent and unknown liabilities as required by Delaware law. Based on this estimated reserve, the Company currently estimates that the aggregate amount of an initial liquidating distribution to shareholders will be between $72.9 million and $77.9 million, or between $2.72 to $2.91 per share, based on 26,817,294 shares of common stock outstanding as of November 2, 2012. The Company expects to make an initial liquidating distribution as soon as practicable following the dissolution.
The amount distributable to shareholders, however, may vary substantially from this estimate based on a number of factors, including the resolution of outstanding known and contingent liabilities, the possible assertion of claims that are currently unknown to the Company and costs incurred to wind down the Company's business. In particular, pursuant to the Company's Separation and Distribution Agreement with its former parent, Myriad Genetics, Inc., at the time of the Company's separation from Myriad Genetics in 2009, the Company assumed liability for certain pending or threatened legal matters related to the Company's business, and is obligated to indemnify Myriad Genetics for any liability arising out of such matters, including any costs of litigating such matters. Although the Company does not believe that any obligation it assumed under the Separation and Distribution Agreement will result in a material liability, it cannot predict with certainty the amount or timing of such liability, if any. The Board of Directors, in consultation with its advisors, has evaluated this contingent liability, as well as other matters, in order to make a determination about reasonable amounts to reserve, which is reflected in the estimated reserve described above. Although the Board of Directors believes there is a reasonable possibility that a substantial amount of the contingency portion of the reserve will ultimately be distributed to the shareholders, Delaware law requires that the Company's Board of Directors make reasonable provision for contingent and unknown obligations in connection with a dissolution and liquidation of the Company, which requires that a portion of the Company's assets be reserved until the resolution of such matters. Further, if additional amounts are ultimately determined to be necessary to satisfy any of these obligations, shareholders may receive substantially less than the current estimates.
If, prior to its dissolution, the Company receives an offer for a transaction that will, in the view of the Board, provide superior value to shareholders than the value of the estimated distributions under the Plan of Dissolution, taking into account all factors that could affect valuation, including timing and certainty of payment or closing, credit market risks, proposed terms and other factors, the Plan of Dissolution and the dissolution could be abandoned in favor of such a transaction.
IMPORTANT ADDITIONAL INFORMATION WILL BE FILED WITH THE SEC
This press release is for informational purposes only. It is neither a solicitation of a proxy, an offer to purchase, nor a solicitation of an offer to sell shares of Myrexis, Inc. In connection with the proposed Plan of Dissolution, the Company intends to file with the Securities and Exchange Commission ("SEC") a proxy statement and other relevant materials. THE COMPANY'S SHAREHOLDERS ARE URGED TO READ THE PROXY STATEMENT AND THE OTHER RELEVANT MATERIALS WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY AND THE PLAN OF DISSOLUTION. Shareholders may obtain a free copy of the proxy statement and the other relevant materials (when they become available), and any other documents filed by the Company with the SEC, at the SEC's website at http://www.sec.gov. In addition, the Company will mail a copy of the definitive proxy statement to shareholders of record on the record date when it becomes available. A free copy of the proxy statement when it becomes available and other documents filed with the SEC by the Company may also be obtained free of charge on the "Investors" section of Myrexis' website at www.myrexis.com or by directing a written request to: Myrexis, Inc., Attn: Secretary, 305 Chipeta Way, Salt Lake City, Utah 84108, or by contacting the Investor Relations department of Myrexis, Inc. at (801) 214-7800.
Participants in the Solicitation
Myrexis and its executive officers and directors may be deemed to be participants in the solicitation of proxies from its shareholders with respect to the proposed Plan of Dissolution. Information regarding their direct or indirect interests, by security holdings or otherwise, in the solicitation will be included in the proxy statement filed by Myrexis with the SEC.
Certain U.S. Federal Income Tax Consequences to U.S. Stockholders
The following summary describes certain material U.S. federal income tax consequences to U.S. holders of Myrexis common stock related to the Plan of Dissolution. Unless otherwise specifically indicated herein, this summary addresses the tax consequences only to a beneficial owner of Myrexis common stock that for U.S. income tax purposes is: (1) a citizen or individual resident of the U.S., (2) a corporation organized in or under the laws of the U.S. or any state thereof or the District of Columbia, (3) an estate whose income is subject to U.S. federal income taxation regardless of its source, or (4) any trust if a U.S. court is able to exercise primary supervision over the administration of such trust and one or more U.S. persons have the authority to control all substantial decisions of the trust, or it has a valid election in place to be treated as a U.S. person (a "U.S. holder"), and, even with respect to such beneficial owners, this summary does not address special considerations that may be applicable to certain specific categories of investors.
Amounts received by stockholders pursuant to the Plan of Dissolution will be applied against and reduce a stockholder's tax basis in his, her or its shares of stock. Gain will be recognized as a result of a liquidating distribution to the extent that the aggregate value of the distribution and any prior liquidating distributions received by a stockholder with respect to a share exceeds his, her or its tax basis for that share. If the Company makes more than one liquidating distribution, each liquidating distribution will be allocated proportionately to each share of stock owned by a stockholder. Any loss will generally be recognized only when the final distribution from the Company has been received and then only if the aggregate value of all liquidating distributions with respect to a share is less than the stockholder's tax basis for that share. Gain or loss recognized by a stockholder will be capital gain or loss provided the shares are held as capital assets, and will be long term capital gain or loss if the stock has been held for more than one year. If no distributions are made to the stockholders, each stockholder will generally recognize a capital loss equal to the stockholder's basis in his, her or its shares. Such loss will be recognized on the last day of the year in which the stock became worthless as if sold on that day. Although we currently do not intend to make distributions of property other than cash, in the event of a distribution of property, the stockholder's tax basis in such property immediately after the distribution will be the fair market value of such property at the time of distribution.
The tax consequences of the Plan of Dissolution may vary depending upon the particular circumstances of the stockholder. The Company recommends that each stockholder consult his, her or its own tax advisor regarding the federal income tax consequences of the Plan of Dissolution as well as the state, local and foreign tax consequences. Furthermore, each stockholder should review the more detailed discussion of U.S. federal income tax consequences to U.S. stockholders that will be included in the proxy statement to be filed with the SEC.
Cautionary Statement About Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements relating to the estimate of the reserve to be established to pay all expenses and other known, non-contingent liabilities, expenses of liquidation and contingent and unknown liabilities and the estimate of an initial liquidating distribution. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "intend," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of these terms or other terminology.
Forward-looking statements are based on the opinions and estimates of management at the time the statements are made and are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. The Company's actual results may differ materially from those expressed or implied by these forward-looking statements based on a number of factors, including failure of the Company's shareholders to approve the proposed Plan of Dissolution, the Company's ability to settle, make reasonable provision for or otherwise resolve its liabilities and obligations, including the establishment of an adequate contingency reserve, and the other risks and uncertainties described in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2012, as updated from time to time in the Company's subsequent SEC filings. Readers are cautioned that these forward-looking statements, including, without limitation, statements regarding the dissolution and liquidation of the Company pursuant to the terms of the Plan of Dissolution, the availability, amount or timing of liquidating distributions to shareholders, the adequacy of reserves established to satisfy the Company's obligations and the belief that a substantial amount of the contingency portion of the reserve will ultimately be distributed to the shareholders, and other statements contained in this press release regarding matters that are not historical facts, are only estimates or predictions. Readers are cautioned not to place undue reliance upon these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to update any forward-looking statements whether as a result of new information, future events or other factors, except as required by law.
The Myrexis, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=9929
CONTACT: Myrexis
Andrea Kendell
Chief Financial Officer
(801) 214-7879
investor.relations@myrexis.com
The Ruth Group (on behalf of Myrexis)
Stephanie Carrington (investors)
(646) 536-7017
scarrington@theruthgroup.com
Tracy Lessor, Ph.D. (media)
(646) 536-7006
tlessor@theruthgroup.com
BIG Money flowing into MYRX now, follow the money...someone knows something more than the public
$MYRX: 478,490 shares were just bought at .18, that's $86,128..dang, makes you wonder....hmmm
Big buys starting to go through. I sent an email to the company, will post response.
All I know is the chart looks like it should be trading higher.
MYRX:An acquisition or payment of the distribution would require an 8-k since they are material events....HAS NOT HAPPENED yet imo This is a freak situation they could pay off nicely. jmho
Ya never know...might be worth a shot.
That's what I see too. gl to us!
I've seen screw ups before that created a golden opp for those that grabbed it early. MYRX could run back over a dollar fast if I'm correct
I agree and got in!! ")
MYRX: MYRX: Read this link. It almost seems to me as if the MMs made a mistake today reducing the pps by $2.86 as the distribution has not been paid. MYRX just resumed trading on the OTC after NASDAQ delist. Could be a boon here. READ IT and tell what you think.
http://investors.myrexis.com/releasedetail.cfm?ReleaseID=735228
It would almost seem as though the MMs made a mistake by reducing the pps today as this is not payable immediately.
You are correct..
"We believe that these arrangements will maximize value to our shareholders by providing an immediate substantial cash distribution to shareholders, while preserving and enhancing the opportunity to derive additional value in the future."
Exactly. There's been no news about a revenue producing acquisition, which was how they planned on paying the shareholders, right? Or am I reading it wrong...?
I wonder when they will pay it since they decided not to dissolve??
as soon as practicable after such date.????
The Board of Directors has declared a special cash distribution to shareholders in the amount of $2.86 per share. The special cash distribution will be paid to shareholders of record at the close of business on Monday, February 4, 2013, the record date, as soon as practicable after such date.
http://investors.myrexis.com/releasedetail.cfm?ReleaseID=735228
You could be right...
I have a feeling MYRX is going to make a huge move up, by eod or tomorrow!! ^^^ jmo
Did they pay it?
How did they pay this dividend then?
Corporate Actions
Ex. Date Record Date Pay Date
Dividend (2.86) Feb 19, 2013 Feb 04, 2013 Feb 15, 2013
http://www.otcmarkets.com/stock/MYRX/company-info
Dunno...maybe cuz they're broke?
Why isn't more people buying the .14/share MYRX? Seems way undervalued to me.
MYRX delisted from Amex to OTC:
http://www.otcbb.com/asp/dailylist_detail.asp?d=01/31/2013&mkt_ctg=NON-OTCBB
Myrexis, Inc. Announces the Cancellation of Its Upcoming Shareholder Meeting
Board Approves a Special Cash Distribution and the Appointment of a New Director and Chief Executive Officer
Tax Benefits Preservation Rights Plan Remains in Effect
SALT LAKE CITY, Jan. 23, 2013 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX) today announced that its Board of Directors has unanimously determined to cancel the special meeting of its shareholders scheduled for January 23, 2013 at which the Company had been intending to seek approval by the shareholders of a Plan of Complete Liquidation and Dissolution (the "Plan of Dissolution"). The Board of Directors has decided, after extensive and careful consideration of strategic alternatives, to abandon the Proposed Plan of Dissolution and instead implement the arrangements described below, which the Board of Directors believes will create the greatest value for the Company and its shareholders:
The Board of Directors has declared a special cash distribution to shareholders in the amount of $2.86 per share. The special cash distribution will be paid to shareholders of record at the close of business on Monday, February 4, 2013, the record date, as soon as practicable after such date. The Board has also appointed Jonathan M. Couchman as a Class II director of the Company and as its President and Chief Executive Officer, and the remaining members of the Board have resigned. The Company, under the leadership of Mr. Couchman, will continue its evaluation of strategic alternatives.
"After a lengthy review and evaluation of potential alternatives to the Company's liquidation and dissolution, including consideration of advice provided by the Company's financial advisor, Stifel Nicolaus Weisel, the Board of Directors reached the conclusion that it is in the best interests of the shareholders to terminate further consideration of dissolution, appoint Jonathan M. Couchman as Director, President and Chief Executive Officer of the Company, and distribute $2.86 per share to the shareholders. Mr. Couchman has an established track record in creating value for shareholders, and he will endeavor to identify and cause the company to acquire one or more revenue or income producing assets," stated Gerald P. Belle, Chairman of the Board of Directors. "We believe that these arrangements will maximize value to our shareholders by providing an immediate substantial cash distribution to shareholders, while preserving and enhancing the opportunity to derive additional value in the future."
"I am excited by the challenge to identify and pursue opportunities to maximize value for Myrexis and for its stockholders and am encouraged by the platform for growth which it provides, including its recognizable brand, infrastructure and intangibles, as well as its remaining intellectual property, comprising license agreements with DFH Pharma and UNC Chapel Hill," said Mr. Couchman. "I am impressed by the thoroughness and dedication of the Board of Directors in their evaluation of strategic alternatives and appreciate the opportunity to continue to pursue opportunities to further maximize value for shareholders, including the potential for a private to public reverse merger, investments and acquisitions among other alternatives."
Jonathan M. Couchman serves as Chairman of the Board, Chief Executive Officer and Chief Financial Officer of Xstelos Holdings, Inc., (OTCQB:XTLS) and previously served as Director of Golf Trust of America, during its evaluation of strategic alternatives, which culminated in the reverse merger of privately owned Pernix Therapeutics Holdings, Inc. into Golf Trust of America, effective March 9, 2010.
Stifel Nicolaus Weisel has acted as exclusive financial advisor to Myrexis.
MYREXIS TAX BENEFITS PRESERVATION RIGHTS PLAN
It should be noted that Myrexis adopted a Tax Benefits Preservation Rights Plan, which remains in effect, and which prohibits the ownership of greater than 4.99% of the stock of Myrexis by an individual or a group of stockholders, subject to certain limited exemptions provided therein. The Tax Benefits Preservation Rights Plan is in the form of a Rights Agreement designed to help protect and preserve Myrexis' substantial tax attributes primarily associated with net operating loss carryforwards (NOLs) and research tax credits, under Sections 382 and 383 of the Internal Revenue Code, and is similar to plans adopted by numerous other public companies with significant NOLs.
Certain U.S. Federal Income Tax Consequences to U.S. Stockholders
The following summary describes certain material U.S. federal income tax consequences to U.S. holders of Myrexis common stock related to the special cash distribution. Unless otherwise specifically indicated herein, this summary addresses the tax consequences only to a beneficial owner of Myrexis common stock that for U.S. income tax purposes is: (1) a citizen or individual resident of the U.S., (2) a corporation organized in or under the laws of the U.S. or any state thereof or the District of Columbia, (3) an estate whose income is subject to U.S. federal income taxation regardless of its source, or (4) any trust if a U.S. court is able to exercise primary supervision over the administration of such trust and one or more U.S. persons have the authority to control all substantial decisions of the trust, or it has a valid election in place to be treated as a U.S. person (a "U.S. holder"), and, even with respect to such beneficial owners, this summary does not address special considerations that may be applicable to certain specific categories of investors.
Amounts received by stockholders in connection with the special cash distribution will be taxable as a dividend to the extent of the Company's current or accumulated earnings and profits. Distributions in excess of such earnings and profits will be applied against and reduce a stockholder's tax basis in his, her or its shares of stock. Gain will be recognized as a result of a distribution to the extent that the aggregate value of the distribution received by a stockholder with respect to a share exceeds his, her or its tax basis for that share. Gain recognized by a stockholder will be capital gain provided the shares are held as capital assets, and will be long term capital gain if the stock has been held for more than one year. No loss will be recognized by a stockholder until such time as a stockholder disposes of his, her or its shares of stock.
The tax consequences of the special cash distribution may vary depending upon the particular circumstances of the stockholder. The Company recommends that each stockholder consult his, her or its own tax advisor regarding the federal income tax consequences of the special cash distribution, as well as the state, local and foreign tax consequences.
Cautionary Statement About Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including, without limitation, statements relating to the possibility that the Company may be able to acquire one or more revenue or income generating assets in the future and the potential for opportunities to further maximize value for shareholders, including the potential for a private to public reverse merger, investments and acquisitions among other alternatives. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "intend," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of these terms or other terminology.
Forward-looking statements are based on the opinions and estimates of management at the time the statements are made and are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. The Company's actual results may differ materially from those expressed or implied by these forward-looking statements based on a number of factors, including the Company's failure to acquire one or more revenue or income generating assets or to identify and execute upon any opportunities to further maximize value for shareholders, and other risks and uncertainties described in the Company's Annual Report on Form 10-K for the fiscal year ended June 30, 2012, as updated from time to time in the Company's subsequent SEC filings. Readers are cautioned that these forward-looking statements and other statements contained in this press release regarding matters that are not historical facts, are only estimates or predictions. Readers are cautioned not to place undue reliance upon these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to update any forward-looking statements whether as a result of new information, future events or other factors, except as required by law.
The Myrexis, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=9929
Total Cash (mrq): 84.34M
Total Cash Per Share (mrq): 3.15
Total Debt (mrq): 0.00
Total Debt/Equity (mrq): N/A
Current Ratio (mrq): 56.60
Book Value Per Share (mrq): 3.21
Myrexis Announces Death of Chief Executive Officer Richard B. Brewer, Trailblazing Biotechnology Industry Veteran and Patient Advocate
Press Release: Myrexis, Inc. – Wed, Aug 15, 2012 12:34 PM EDT.. .
SALT LAKE CITY, UT and MONTEREY, CA--(Marketwire -08/15/12)- Myrexis, Inc. (MYRX) announced today that Richard B. Brewer, 61, its Chief Executive Officer and Board member, has died after a long battle with multiple myeloma, a type of blood cancer.
"Dick was a one-of-a-kind trailblazer and visionary who made an indelible mark on the biotech industry and on the lives of the many colleagues he inspired and influenced, family and friends he loved and enjoyed, and patients who benefited from his risk-taking work and advocacy," said David W. Gryska, Chief Operating Officer of Myrexis and long-time colleague of Brewer. "Dick was not only a fearless, dedicated and passionate biopharmaceutical executive for over 35 years who helped bring to market several important medicines that have saved, improved and extended the lives of many. He was also a patient himself who survived multiple myeloma almost twice as long as the average life expectancy for the disease, trying experimental and aggressive therapeutic regimens that could help guide many others in the future."
Brewer joined Myrexis in May 2012 after nearly 35 years in the biotech and pharmaceutical industries guiding development and commercialization of such breakthrough drugs as human growth hormone for children's growth disorders; the first new drug in 30 years for cystic fibrosis; the first new drug in over a decade for heart failure; pioneering clot-busting drugs for heart attacks and strokes; and other first-in-class drugs and devices for cancer and heart disease.
Gryska will become Myrexis' acting CEO until the company communicates its succession plans in the coming weeks.
About Myrexis, Inc.
Myrexis, Inc. is a biopharmaceutical company headquartered in Salt Lake City, Utah, focused on identifying, evaluating and acquiring commercial-stage biopharmaceutical assets. Myrexis' goal is to build a commercial-stage biopharmaceutical company by acquiring one or more life sciences assets and optimizing their performance and profitability.
2 Pharmaceutical Companies Trading Below Net Cash - Part II
http://seekingalpha.com/article/625921-2-pharmaceutical-companies-trading-below-net-cash-part-ii?source=yahoo
8:32AM Myrexis adopts tax benefits preservation rights plan to protect use of net operating losses replacing existing shareholder rights plan (MYRX) 3.08 : Co announced today that its Board of Directors has adopted a Tax Benefits Preservation Rights Plan in the form of a Rights Agreement designed to help protect and preserve its substantial tax attributes primarily associated with net operating loss carryforwards (NOLs) and research tax credits, under Sections 382 and 383 of the Internal Revenue Code. As of December 31, 2011, Myrexis had tax attributes, including net operating losses and research tax credits, of approximately $107 mln that could be used in certain circumstances to offset Myrexis' future taxable income and reduce its federal and state income tax liability. As part of the plan, on March 29, 2012, Myrexis' Board of Directors declared a dividend of one preferred share purchase right for each share of Myrexis common stock outstanding as of April 9, 2012.
~ $MYRX ~ Earnings posted, pending or coming soon! In Charts and Links Below!
~ $MYRX ~ Earnings expected on Monday *
This Week In Earnings: Earnings are coming or are already posted! This is what the charts look like! If you play the earnings these posts can be very helpful to you!
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.
http://stockcharts.com/h-sc/ui?s=MYRX&p=D&b=3&g=0&id=p88783918276&a=237480049
http://stockcharts.com/h-sc/ui?s=MYRX&p=W&b=3&g=0&id=p54550695994
~ Barchart: http://barchart.com/quotes/stocks/MYRX?
~ OTC Markets: http://www.otcmarkets.com/stock/MYRX/company-info
~ Google Finance: http://www.google.com/finance?q=MYRX
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=MYRX#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=MYRX+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=MYRX
Finviz: http://finviz.com/quote.ashx?t=MYRX
~ BusyStock: http://busystock.com/i.php?s=MYRX&v=2
~ CandlestickChart: http://www.candlestickchart.com/cgi/chart.cgi?symbol=MYRX&exchange=US
~ Investorshub Trades: http://ih.advfn.com/p.php?pid=trades&symbol=MYRX
~ Investorshub Board Search: http://investorshub.advfn.com/boards/getboards.aspx?searchstr=MYRX
~ Investorshub PostStream Search: http://investorshub.advfn.com/boards/poststream.aspx?ticker=MYRX
~ Investorshub Goodies Search: http://investorshub.advfn.com/boards/msgsearchbyboard.aspx?boardID=18582&srchyr=2011&SearchStr=MYRX
~ Investorshub Message Search: http://investorshub.advfn.com/boards/msgsearch.aspx?SearchStr=MYRX
~ MarketWatch: http://www.marketwatch.com/investing/stock/MYRX/profile
~ E-Zone Chart: http://www.windchart.com/ezone/signals/?symbol=MYRX
~ 5-Min Wind: http://www.windchart.com/stockta/analysis?symbol=MYRX
~ 10-Min Wind: http://www.windchart.com/stockta/analysis?symbol=MYRX&size=l&frequency=10&color=g
~ 30-Min Wind: http://www.windchart.com/stockta/analysis?symbol=MYRX&size=l&frequency=30&color=g
~ 60-Min Wind: http://www.windchart.com/stockta/analysis?symbol=MYRX&size=l&frequency=60&color=g
http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916
*If the earnings date is in error please ignore error. I do my best.
Total Cash (mrq): 100.59M
Total Cash Per Share (mrq): 3.83
Total Debt (mrq): 0.00
Total Debt/Equity (mrq): N/A
Current Ratio (mrq): 32.09
Book Value Per Share (mrq): 4.21
http://quotes.barrons.com/myrx/ownership
http://www.insidercow.com/history/company.jsp?company=myrx&B1=Search!
Followers
|
25
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
348
|
Created
|
09/13/09
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |